MCK
McKesson Corporation · Healthcare · Medical - Distribution
Momentum inputs (comparable managers):
holder breadth -5.3% ·
share flow -4.1% ·
net new positions -5.6%
— formula
Broad distribution — falling shares and fewer holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q1 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 172 | 0 | 84.73M | $64.19B | +6 | −5 |
| Q1 2026 | 174 | 0 | 86.49M | $74.72B | +5 | −6 |
| Q4 2025 | 173 | +2 | 91.21M | $74.82B | +3 | — |
| Q3 2025 | 22 | 0 | 48.07M | $37.12B | +1 | −2 |
| Q2 2025 | 20 | -1 | 40.25M | $29.48B | — | −1 |
| Q1 2025 | 18 | -1 | 15.05M | $10.13B | +1 | −2 |
| Q4 2024 | 19 | +1 | 15.70M | $8.94B | +1 | — |
| Q3 2024 | 17 | -1 | 9.08M | $4.48B | +1 | −2 |
| Q2 2024 | 18 | — | 11.69M | $6.82B | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (passive) | 5.69M | -0.3% | $3.84B | 0.2% | ▼ Trim | 2 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passive) | 2.71M | +1.7% | $1.82B | 0.1% | ▲ Add | 4 | SEC ↗ ×2 |
| 3 | Norges Bank ✦ (passive) | 1.77M | -16.2% | $1.19B | 0.2% | ▼ Trim | 4 | SEC ↗ |
| 4 | T. Rowe Price ✦ | 1.29M | +9.1% | $868.24M | 0.1% | ▲ Add | 4 | SEC ↗ ×2 |
| 5 | AQR Capital Management ✦ | 954.71K | +3.5% | $642.51M | 0.7% | ▲ Add | 4 | SEC ↗ ×7 |
| 6 | Arrowstreet Capital ✦ | 790.48K | -14.9% | $531.98M | 0.4% | ▼ Trim | 4 | SEC ↗ |
| 7 | Wellington Management ✦ | 427.70K | +4559.6% | $287.84M | 0.1% | ▲ Add | 4 | SEC ↗ ×9 |
| 8 | Marshall Wace ✦ | 391.65K | +9.1% | $263.58M | 0.4% | ▲ Add | 4 | SEC ↗ ×3 |
| 9 | Two Sigma Investments ✦ | 325.93K | +97.8% | $219.35M | 0.5% | ▲ Add | 4 | SEC ↗ |
| 10 | Adage Capital Partners ✦ | 218.13K | +14.2% | $146.80M | 0.3% | ▲ Add | 4 | SEC ↗ |
| 11 | Bridgewater Associates ✦ | 156.21K | -52.6% | $105.13M | 0.5% | ▼ Trim | 4 | SEC ↗ |
| 12 | Millennium Management ✦ | 124.57K | -29.2% | $83.83M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 13 | Glenview Capital ✦ | 81.85K | -46.0% | $55.09M | 1.4% | ▼ Trim | 4 | SEC ↗ |
| 14 | D. E. Shaw & Co. ✦ | 77.70K | -68.1% | $52.29M | 0.1% | ▼ Trim | 4 | SEC ↗ ×2 |
| 15 | Gotham Asset Management ✦ | 26.77K | -11.8% | $18.02M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 16 | Soros Fund Management ✦ | 15.00K | New | $10.09M | 0.3% | New | 1 | SEC ↗ |
| 17 | Fisher Asset Management ✦ | 1.00K | +8.9% | $676,886 | 0.0% | ▲ Add | 4 | SEC ↗ |
| 18 | Renaissance Technologies ✦ | 800 | -99.7% | $538,392 | 0.0% | ▼ Trim | 3 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| Soros Fund Management | $10.09M | 0.3% |
Exited
| Citadel Advisors | $107.97M | was 0.1% |
| Point72 Asset Management | $58.59M | was 0.2% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 2,017 holders, 102.83M shares, $85.35B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Officer · 111 sh · $98,951
Director · 301 sh · $268,590
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology